Evidence map›Paper›PMID 38173768›Full record

ReviewRegenerative biomaterials2024

Status and developmental trends in recombinant collagen preparation technology.

Xiaolei Guo, Yuan Ma, Hang Wang, Hongping Yin, Xinli Shi, Yiqin Chen, Guobiao Gao, Lei Sun, Jiadao Wang, Yunbing Wang and 1 more

Abstract readReview
In one paragraph

Review in Regenerative biomaterials, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Scaling Cultured Meat: Challenges and Solutions for Affordable Mass Production.Comprehensive reviews in food science and food safety · 2025
    Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Xiaolei GuoCenter for Medical Device Evaluation, National Medical Products Administration, Beijing 100081, China.ORCID https://orcid.org/0000-0002-5088-2959
Yuan MaState Key Laboratory of Tribology, Tsinghua University, Beijing 100084, China.
Hang WangSchool of Life Science and Technology, China Pharmaceutical University, Nanjing 210009, China.
Hongping YinSchool of Life Science and Technology, China Pharmaceutical University, Nanjing 210009, China.
Xinli ShiCenter for Medical Device Evaluation, National Medical Products Administration, Beijing 100081, China.
Yiqin ChenState Key Laboratory of Tribology, Tsinghua University, Beijing 100084, China.
Guobiao GaoCenter for Medical Device Evaluation, National Medical Products Administration, Beijing 100081, China.
Lei SunCenter for Medical Device Evaluation, National Medical Products Administration, Beijing 100081, China.
Jiadao WangState Key Laboratory of Tribology, Tsinghua University, Beijing 100084, China.
Yunbing WangNational Engineering Research Center for Biomaterials & College of Biomedical Engineering, Sichuan University, Chengdu 610064, China.
Daidi FanBiotech. & Biomed. Research Institute, Northwest University, Xi'an 710127, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recombinant collagen is a pivotal topic in foundational biological research and epitomizes the application of critical bioengineering technologies. These technological advancements have profound implications across diverse areas such as regenerative medicine, organ replacement, tissue engineering, cosmetics and more. Thus, recombinant collagen and its preparation methodologies rooted in genetically engineered cells mark pivotal milestones in medical product research. This article provides a comprehensive overview of the current genetic engineering technologies and methods used in the production of recombinant collagen, as well as the conventional production process and quality control detection methods for this material. Furthermore, the discussion extends to foresee the strides in physical transfection and magnetic control sorting studies, envisioning an enhanced preparation of recombinant collagen-seeded cells to further fuel recombinant collagen production.

Indexed as

collagen characterizationgenetic engineeringphysical transfectionrecombinant collagen preparationseed cell sorting

Identifiers

PMID38173768
PMCPMC10761200

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.